Hematology › Forums › Hematology MCQ discussion forum › NEET SS Clinical Hematology 2020 Telegram Group Discussion MCQs › Reply To: NEET SS Clinical Hematology 2020 Telegram Group Discussion MCQs
Q51-60 = Based on adverse events of chemotherapeutic agents !
51. Which of the following is not a adverse event with L-Asparginase administration ?
[1] Pancreatitis
[2] Hepatitis
[3] Neuritis
[4] Hypersensitivity
52. Which of the following is implicated in increased thrombotic risk in ALL induction therapy ?
[1] L-Asparginase
[2] Prednisolone
[3] Both A and B
[4] None of these
53. Major dose limiting toxicity of vincristine ?
[1] Neutropenia
[2] Thrombocytopenia
[3] Neurotoxicity
[4] Diarrhoea
54. Which of the following is implicated in cardiotoxicity ?
[1] Vinblastine
[2] Doxorubicin
[3] L-Asparginase
[4] All of these
55. PRES during ALL induction therapy is attributed mainly as adverse effect of ?
[1] Prednisolone
[2] L-Asparginase
[3] Doxorubicin
[4] Vincristine